Overview

Study of Antenatal Thyrotropin-Releasing Hormone in Women in Premature Labor to Prevent Lung Disease in Preterm Infants

Status:
Completed
Trial end date:
1998-06-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Assess the efficacy and safety of antenatal administration of thyrotropin-releasing hormone to women in premature labor to improve pulmonary outcomes in preterm infants.
Phase:
N/A
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator:
Children's Hospital of Philadelphia
Treatments:
Calcitonin
Hormones
Thyrotropin-Releasing Hormone